
血液肿瘤内科
血液癌中心 血液肿瘤内科
Lymphocytic leukemia
,
Blood cancer
,
Lymphoma
,
Multiple myeloma
,
Amyloidosis
,
Thrombocytopenia
,
Precision Medicine
,
Clinical trial
,
Personalized treatment
Lymphocytic leukemia
,
Blood cancer
,
Lymphoma
,
Multiple myeloma
,
Amyloidosis
,
Thrombocytopenia
,
Precision Medicine
,
Clinical trial
,
Personalized treatment
Education / Career
Article | Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype | ||
---|---|---|---|
Announcements | International journal of hematology | Date of publication | 2009 |
Co-researcher |
Article | Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway | ||
---|---|---|---|
Announcements | Annals of hematology | Date of publication | 2009 |
Co-researcher |
Article | Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma | ||
---|---|---|---|
Announcements | Annals of oncology | Date of publication | 2009 |
Co-researcher |
Article | Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide. | ||
---|---|---|---|
Announcements | Annals of hematology | Date of publication | 2010 |
Co-researcher |
Article | Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer | ||
---|---|---|---|
Announcements | Journal of thoracic oncology | Date of publication | 2010 |
Co-researcher |
Article | Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA) | ||
---|---|---|---|
Announcements | Leukemia research | Date of publication | 2010 |
Co-researcher |
Article | Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8 | ||
---|---|---|---|
Announcements | Japanese journal of clinical oncology | Date of publication | 2010 |
Co-researcher |
Article | GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization | ||
---|---|---|---|
Announcements | Cancer genetics and cytogenetics | Date of publication | 2010 |
Co-researcher |
Article | EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma | ||
---|---|---|---|
Announcements | Japanese journal of clinical oncology | Date of publication | 2011 |
Co-researcher |
Article | Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors | ||
---|---|---|---|
Announcements | Journal of thoracic oncology | Date of publication | 2011 |
Co-researcher |
Article | The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use | ||
---|---|---|---|
Announcements | Japanese journal of clinical oncology | Date of publication | 2012 |
Co-researcher |
Article | Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation | ||
---|---|---|---|
Announcements | Biology of blood and marrow transplantation | Date of publication | 2012 |
Co-researcher |
Article | Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma | ||
---|---|---|---|
Announcements | Annals of oncology | Date of publication | 2013 |
Co-researcher |
Article | Application of array comparative genomic hybridization in chronic myeloid leukemia. | ||
---|---|---|---|
Announcements | Methods in molecular biology | Date of publication | 2013 |
Co-researcher |
Article | Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients | ||
---|---|---|---|
Announcements | American journal of hematology | Date of publication | 2013 |
Co-researcher |
Article | VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib | ||
---|---|---|---|
Announcements | Diagnostic molecular pathology | Date of publication | 2011 |
Co-researcher |